GlucoTrack, Inc.
GCTK
$0.1714
-$0.0026-1.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 81.40% | 31.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.55% | -27.61% | |||
| Operating Income | -18.55% | 27.61% | |||
| Income Before Tax | -98.43% | -13.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -98.43% | -13.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -98.43% | -13.32% | |||
| EBIT | -18.55% | 27.61% | |||
| EBITDA | -18.48% | 27.67% | |||
| EPS Basic | -7.30% | -10.91% | |||
| Normalized Basic EPS | 63.74% | -10.91% | |||
| EPS Diluted | -7.30% | -10.91% | |||
| Normalized Diluted EPS | 63.74% | -10.91% | |||
| Average Basic Shares Outstanding | 84.95% | 2.15% | |||
| Average Diluted Shares Outstanding | 84.95% | 2.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||